Hunter Immunology Overview

  • Founded
  • 2003

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Hunter Immunology General Information

Description

Developer of medicinal drugs intended to treat patient suffering from chronic obstructive pulmonary disease (COPD).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Acquirer
Bioxyne
Primary Office
  • Avalon Parade 61
  • Sydney, New South Wales 2107
  • Australia

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hunter Immunology Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Hunter Immunology‘s full profile, request access.

Request a free trial

Hunter Immunology Patents

Hunter Immunology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2013901154-A0 Killed bacterial treatment of otitis media Inactive 04-Apr-2013
AU-2012901052-A0 Oral pharmaceutical and method of treatment of otitis media Inactive 16-Mar-2012
AU-2009294321-B2 Non-typeable haemophilus influenzae vaccines and their uses Active 17-Sep-2008 0000000000 0
US-20110206765-A1 Non-typeable haemophilus influenzae vaccines and their uses Active 17-Sep-2008 0000000000
EP-2334311-A2 Non-typeable haemophilus influenzae vaccines and their uses Active 17-Sep-2008 A61K39/102
To view Hunter Immunology’s complete patent history, request access »

Hunter Immunology Executive Team (1)

Name Title Board Seat Contact Info
David Radford Chief Executive Officer
To view Hunter Immunology’s complete executive team members history, request access »